This is a promotional website intended for GB healthcare professionals. If you are a member of the public, please click here.
We offer content that is individually tailored to your field of expertise and your needs. To make this possible, we ensure technically that the content that interests you and your area of expertise can be evaluated. For this we need your approval in advance: I agree that Radioligand Therapy Hub evaluates my user behavior, as described in more detail here. I can revoke this consent at any time with effect for the future.
Advanced Accelerator Applications and its affiliates ('AAA') would like to:
You can opt out of receiving these communications at any time by clicking on the relevant link in the emails we send you, or by contacting your AAA representative. Please note that it may still be necessary to send you other communications such as safety information on our products. To improve our services and tailor the communications we send you, we may monitor how you interact with our emails and this site.
In accordance with the ABPI Code of Practice for the Pharmaceutical Industry, AAA will send promotional emails only with your consent and in accordance with this notice.
For further information about the processing of your personal information and your data privacy rights, please refer to our Privacy Notices.
I consent to receive email communications from Novartis.
Please confirm whether you are a UK healthcare professional or a member of public.